ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

ETF Overview

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Key Stats

• Today's Range: $16.75 to $17.46
• 50-Day Range: $17.02 to $21.02
• 52-Week Range: $14.05 to $25.87
• Volume: 24,309 shs
• Average Volume: 12,481 shs
• Market Capitalization: $2.87 million
• Assets Under Management: $2.98 million
• Dividend Yield: 3.49%
• Net Expense Ratio: 0.95%
• Aggregate Rating: N/A

BIS ETF - Frequently Asked Questions

How have BIS shares performed this year?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.19 at the beginning of 2025. Since then, BIS shares have decreased by 7.1% and is now trading at $16.89.
View the best growth stocks for 2025 here.

When did ProShares UltraShort Nasdaq Biotechnology's stock split?

Shares of ProShares UltraShort Nasdaq Biotechnology reverse split before market open on Tuesday, August 18th 2020.The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Fund Details

• Issuer: ProShares
• Fund Name: ProShares UltraShort Nasdaq Biotechnology
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:BIS
• Inception Date: 4/6/2010
• Fund Manager: Michael Neches, Tarak Dave
• Web: www.proshares.com
• Phone: +1-240-4976400

Fund Focus

• Asset Class: Equity
• Benchmark: Nasdaq Biotechnology Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 16

Fund Statistics

• Assets Under Management: $2.98 million
• Average Daily Volume: $14.91 thousand
• Discount/Premium: 0.02%
• Leveraged: -2.00

Administrator, Advisor and Custodian

• Administrator: J.P. Morgan Investor Services Co.
• Advisor: ProShare Advisors, LLC
• Custodian: JPMorgan Chase Bank, N.A.
• Distributor: SEI Investments Distribution Co.
• Transfer Agent: J.P. Morgan Chase Bank, N.A.
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 14,700 shs

Miscellaneous

• Outstanding Shares: 170,000
• Beta: -1.41
• Creation Unit: 50,000
• Creation Fee: $250.00